Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Latest News

  • 1
    News

    Statins again linked to lower COVID-19 mortality

    July 21, 2021

    Patients hospitalized for COVID-19 who had been taking statins had a substantially lower risk of death and severe outcomes than those who weren’t in a large observational study.

  • News

    ‘Dealing with a different beast’: Why Delta has doctors worried

    July 21, 2021

    “We are either going to get vaccinated and end the pandemic, or we’re going to accept death and a lot of it.”

  • 1
    News

    Empirical anti-MRSA therapy does not improve mortality in patients with pneumonia

    July 21, 2021

    Does empirical anti–methicillin-resistant Staphylococcus aureus (MRSA) therapy affect 30-day mortality in patients hospitalized with pneumonia, when compared with standard antibiotic regimens?

  • 1
    News

    Children and COVID: New vaccinations increase as cases continue to climb

    July 20, 2021

    Vaccine initiations among children aged 12-15 years had declined in 6 of the previous 7 weeks.

  • News

    HIV increases risk for severe COVID-19

    July 20, 2021

    “We don’t have any information from this about the T-cell counts [or] the rates of viral suppression, which I think is tremendously important,” one physician said about the data.

  • 1
    News

    Pharmacologic and electrical cardioversion of acute Afib reduces hospital admissions

    July 20, 2021

    Is pharmacologic cardioversion and/or electrical cardioversion an appropriate initial management strategy for acute atrial fibrillation?

  • 1
    News

    Long COVID seen in patients with severe and mild disease

    July 20, 2021

    A Swiss study shows how even mild COVID cases can lead to debilitating symptoms, according to Dr. Christopher Terndrup.

  • 1
    News

    Treatment of opioid use disorder with buprenorphine and methadone effective but underutilized

    July 19, 2021

    In clinical practice, what is the effectiveness of different treatment pathways for opioid use disorder?

  • News

    Large remdesivir study finds no COVID-19 survival benefit

    July 16, 2021

    “There is still uncertainty about the role of remdesivir in treatment for people hospitalized with COVID-19,” said Dr. Ohl.

  • 1
    News

    DOACs linked to lower mortality than vitamin K antagonist: 3-year TAVR registry

    July 16, 2021

    Mortality and bleeding advantage favors DOACs over VKA in TAVR patients who are candidates for anticoagulation.

Previous1 … 105 106 107 108 109 … 364Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences